Financials

  • Market Capitalization 11.23 B
  • Employee 5 400
  • Founded 2000
  • CEO Ashley Mcevoy
  • Website www.insulet.com
  • Headquarter Delaware, United States
  • FIGI BBG000R7XX87
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
49.03
Price to sales ratio
5.13

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
749
SNN
Smith & Nephew SNATS Inc
31.08 USD+1.24%+0.55%+1.30%-15.20%13.64 B USD
790
PEN
Penumbra, Inc. Common Stock
318.94 USD+0.26%-0.09%-0.08%+22.67%12.54 B USD
873
GMED
Globus Medical, Inc. Class A Common Stock
79.72 USD+2.05%-2.05%+1.13%+37.73%10.82 B USD
974
GKOS
Glaukos Corporation Common Stock
152.87 USD+0.07%+2.60%+19.39%+46.12%8.98 B USD

Frequently asked questions about Insulet Corporation - Common Stock

What is the Insulet Corporation - Common Stock stock price today?

The current price of Insulet Corporation - Common Stock (PODD) is 162.06. Over the past 24 hours, the stock has changed by +0.48%. Follow the PODD chart for real-time price dynamics.

What is the stock ticker of Insulet Corporation - Common Stock?

Insulet Corporation - Common Stock trades under the ticker PODD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Insulet Corporation - Common Stock stock going up?

PODD has changed by -1.08% over the last week, +8.60% over the last month, and -44.68% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Insulet Corporation - Common Stock net income for the last quarter?

Insulet Corporation - Common Stock reported net income of 91.1 M for the last quarter. The previous quarter showed 101.6 M, which means net income changed by -10.33%.

How many employees does Insulet Corporation - Common Stock have?

As of the latest available data, Insulet Corporation - Common Stock has 5 400 employees. Workforce size can provide additional context about the company's scale and operations.

What is Insulet Corporation - Common Stock EBITDA?

Insulet Corporation - Common Stock EBITDA is 148 M, and its EBITDA margin is 19.43%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Insulet Corporation - Common Stock stock?

You can buy Insulet Corporation - Common Stock (PODD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Insulet Corporation - Common Stock stock?

Investing in Insulet Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PODD chart and related analysis on metatrader.com as part of your research.

News